Ali S. Omrani
About
In The Last Decade
Ali S. Omrani
76 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 1.8k
- Neurology 531
- Epidemiology 466
- Molecular Medicine 325
- Modeling and Simulation 250
Countries citing papers authored by Ali S. Omrani
This map shows the geographic impact of Ali S. Omrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali S. Omrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali S. Omrani more than expected).
Fields of papers citing papers by Ali S. Omrani
This network shows the impact of papers produced by Ali S. Omrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali S. Omrani. The network helps show where Ali S. Omrani may publish in the future.
Co-authorship network of co-authors of Ali S. Omrani
This figure shows the co-authorship network connecting the top 25 collaborators of Ali S. Omrani. A scholar is included among the top collaborators of Ali S. Omrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali S. Omrani. Ali S. Omrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Towards a Unified Framework for Adaptable Problematic Content Detection via Continual Learning | Ali S. Omrani, Jeffrey Sorensen et al. | 0 | |
| 2 | Cost-Efficient Subjective Task Annotation and Modeling through Few-Shot Annotator Adaptation | Ali S. Omrani, Morteza Dehghani et al. | 1 | |
| 3 | Characterization of blaNDM in two Escherichia coli ST1193 clinical isolates in the Gulf region | JAC-Antimicrobial Resistance | Clement K. M. Tsui, Christi L. McElheny et al. | 1 |
| 4 | Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study | Qatar medical journal | Mohamed Saad, Dana Bakdach et al. | 1 |
| 5 | Genomic Epidemiology of Carbapenem-Resistant Klebsiella in Qatar: Emergence and Dissemination of Hypervirulent Klebsiella pneumoniae Sequence Type 383 Strains | Antimicrobial Agents and Chemotherapy | Clement K. M. Tsui, Christi L. McElheny et al. | 20 |
| 6 | Mycobacterium abscessus urinary tract infection in an immunocompetent host: A case report and literature review | IDCases | Ali S. Omrani et al. | 1 |
| 7 | Epidemiology, microbiological and clinical characteristics of Enterococcus species bloodstream infections: A 10-year retrospective cohort study from Qatar | Annals of Medicine and Surgery | Emad Bashir Ibrahim, Muna Al Maslamani et al. | 8 |
| 8 | Which are the best coronavirus disease 2019 vaccines? | Clinical Microbiology and Infection | Ali S. Omrani, Imad M. Tleyjeh | 1 |
| 9 | Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients | Experimental and Clinical Transplantation | Reem S. Almaghrabi, Imran Nizami et al. | 2 |
| 10 | Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature | IDCases | Muna Almaslamani, Abdulsalam Saif Ibrahim et al. | 19 |
| 11 | Middle East respiratory syndrome coronavirus (MERS-CoV) infection | British Journal of Hospital Medicine | Reem S. Almaghrabi, Ali S. Omrani | 13 |
| 12 | Complications of hematopoietic stem transplantation | Hematology/Oncology and Stem Cell Therapy | Ali S. Omrani, Reem S. Almaghrabi | 18 |
| 13 | Complications of hematopoietic stem cell transplantation | Hematology/Oncology and Stem Cell Therapy | Ali S. Omrani, Reem S. Almaghrabi | 20 |
| 14 | Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns | PMC | Jaffar A. Al‐Tawfiq, Ali S. Omrani et al. | 1 |
| 15 | The Relationship between Human Capital and Learning Organization Components in Faculty Members of Imam-Khomeini Hospital Complex in 2011 | scientific journal of ilam university of medical sciences | Malihe Alikhani, Ali S. Omrani et al. | 0 |
| 16 | Analysis of Thraputic Expenditure in Patients with Multiple Sclerosis in Iran | scientific journal of ilam university of medical sciences | Ali S. Omrani, Reza Vafaee et al. | 3 |
| 17 | Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia breakdown → | International Journal of Infectious Diseases | Mustafa Saad, Ali S. Omrani et al. | 391 |
| 18 | Intra-pleural colistin methanesulfonate therapy for pleural infection caused by carbapenem-resistant Acinetobacter baumannii: a successful case report | Infectious Disease Reports | Ahmed Mady, Ali S. Omrani et al. | 9 |
| 19 | Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study breakdown → | The Lancet Infectious Diseases | Ali S. Omrani, Mustafa Saad et al. | 381 |
| 20 | BRONCHOGENIC CARCINOMA PRESENTING AS ABRONCHOPERICARDIAL FISTULA | International Journal of Clinical Practice | Ali S. Omrani, Ross A. Davies et al. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.